Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Scope of the Report:This report focuses on the Growth Factors (Blood and Tissue) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.
The worldwide market for Growth Factors (Blood and Tissue) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2026, from xx million US$ in 2020, according to a new study.
Market Segment by Manufacturers, this report covers Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors
Market Segment by Applications, can be divided into Hospital
Research lab
There are 15 Chapters to deeply display the global Growth Factors (Blood and Tissue) market.
Chapter 1, to describe Growth Factors (Blood and Tissue) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Growth Factors (Blood and Tissue), with sales, revenue, and price of Growth Factors (Blood and Tissue), in 2018 and 2019;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2018 and 2019;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Growth Factors (Blood and Tissue), for each region, from 2015 to 2020;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2015 to 2020;
Chapter 12, Growth Factors (Blood and Tissue) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2026;
Chapter 13, 14 and 15, to describe Growth Factors (Blood and Tissue) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.